Braveheart Bio, Inc. (BRVE) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Sep 30Oct 5Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29

Key dataOct 29, 2026

Open$21.55

From 52W high−28.73%

Volume193244.00

Market cap$1.93B

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataOct 29, 2026

Open

$21.55

From 52W high

−28.73%

Volume

193244.00

Market cap

$1.93B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

P/E (TTM)

—

RSI (14)

50.6

MomentumView details →

1D Return

−1.73%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

—

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

−1.73%

YTD Return

—

1Y Return

—

RSI (14)

50.6

vs 50D SMA

−9.41%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$2.51

EPS Surprise

−193.31%

Beats (12Q)

0/12

Next Q EPS Est

—

Avg Surprise (4Q)

−193.31%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Next earningsDec 8, 2026 →

Latest newsMore news →

No recent news for BRVE.

Similar companies

AIM Vaccine Co., Ltd.06660.HK Xeris Biopharma Holdings, Inc.XERS Shandong Boan Biotechnology Co., Ltd.06955.HK Trevi Therapeutics, Inc.TRVI Mineralys Therapeutics, Inc.MLYS Vir Biotechnology, Inc.VIR Find similar companies →

Latest newsMore news →

No recent news for BRVE.